SEC Filings for Taro Pharmaceutical Industries Ltd. (TARO)

$ 82.43   -1.13 (-1.35%) Volume: 58.73k 3:57 PM EDT 22-Jul-2019
Filing Type:
Form TypeForm DescriptionPagesDateView
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act306/21/2019
20-FAnnual and transition report of foreign private issuers under sections 13 or 15(d)14006/20/2019
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act805/23/2019
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act305/16/2019
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act802/07/2019
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act301/31/2019
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act301/15/2019
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act312/31/2018
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act1012/07/2018
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act3911/07/2018
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act811/05/2018
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act310/29/2018
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act309/28/2018
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act708/10/2018
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act308/02/2018
<<
First
<
Prev
123456789101112131415